| June 27, 2007 |
| March 25, 2009 |
| June 2007 |
| August 2009 (final data collection date for primary outcome measure) |
| Patient-rated leg pain [ Time Frame: short-term = 12 weeks; long-term = 52 weeks ] [ Designated as safety issue: No ] |
| patient-rated leg pain |
| Complete list of historical versions of study NCT00494065 on ClinicalTrials.gov Archive Site |
- Bothersomeness [ Time Frame: short-term = 12 weeks; long-term = 52 weeks ] [ Designated as safety issue: No ]
- Frequency [ Time Frame: short-term = 12 weeks; long-term = 52 weeks ] [ Designated as safety issue: No ]
- Disability [ Time Frame: short-term = 12 weeks; long-term = 52 weeks ] [ Designated as safety issue: No ]
- General Health Status [ Time Frame: short-term = 12 weeks; long-term = 52 weeks ] [ Designated as safety issue: No ]
- Fear Avoidance [ Time Frame: short-term = 12 weeks; long-term = 52 weeks ] [ Designated as safety issue: No ]
- Patient Satisfaction [ Time Frame: short-term = 12 weeks; long-term = 52 weeks ] [ Designated as safety issue: No ]
- Improvement [ Time Frame: short-term = 12 weeks; long-term = 52 weeks ] [ Designated as safety issue: No ]
- Medication Use [ Time Frame: short-term = 12 weeks; long-term = 52 weeks ] [ Designated as safety issue: No ]
- Biomechanical test measures:
Continuous lumbar motion,
Standing postural sway,
Neuromuscular response to a sudden load,
Straight leg raise test,
Torso muscle endurance [ Time Frame: short-term = 12 weeks ] [ Designated as safety issue: No ]
|
- Bothersomeness [ Time Frame: short-term = 12 weeks; long-term = 52 weeks ]
- Frequency [ Time Frame: short-term = 12 weeks; long-term = 52 weeks ]
- Disability [ Time Frame: short-term = 12 weeks; long-term = 52 weeks ]
- General Health Status [ Time Frame: short-term = 12 weeks; long-term = 52 weeks ]
- Fear Avoidance [ Time Frame: short-term = 12 weeks; long-term = 52 weeks ]
- Patient Satisfaction [ Time Frame: short-term = 12 weeks; long-term = 52 weeks ]
- Improvement [ Time Frame: short-term = 12 weeks; long-term = 52 weeks ]
- Medication Use [ Time Frame: short-term = 12 weeks; long-term = 52 weeks ]
- Biomechanical test measures:
CONTINUOUS LUMBAR MOTION,
STANDING POSTURAL SWAY,
NEUROMUSCULAR RESPONSE TO A SUDDEN LOAD,
STRAIGHT LEG RAISE TEST,
TORSO MUSCLE ENDURANCE [ Time Frame: short-term = 12 weeks ]
|
| |
| Chiropractic and Self-Care for Back-Related Leg Pain |
| Chiropractic and Self-Care for Back-Related Leg Pain |
The primary aims of the project are to determine the clinical efficacy of chiropractic Spinal Manipulative Therapy (SMT) plus self-care education versus self-care education alone in 192 patients with sub-acute and chronic Back Related Leg Pain (BRLP) in both the short-term (after 12 weeks) and long-term (after 52 weeks). The primary outcome variable is leg pain and secondary outcome variables include low back pain, disability, bothersomeness and frequency of symptoms, general health status, and fear avoidance behavior.
Secondary aims are to describe and estimate between group differences in patient satisfaction, improvement, medication use, straight leg raise, torso endurance, and three biomechanical measures: continuous spinal motion, postural sway, and neuromuscular response to sudden load. Patient perceptions of treatment will also be assessed. |
| |
| |
| Interventional |
| Treatment, Randomized, Single Blind (Outcomes Assessor), Active Control, Parallel Assignment, Efficacy Study |
| Sub-Acute and Chronic Back-Related Leg Pain |
- Other: Home exercise
- Other: Chiropractic Spinal Manipulative Therapy + Home exercise
|
- Experimental: Chiropractic Spinal Manipulative Therapy + Home exercise
- Active Comparator: Home exercise
|
| |
| |
| Recruiting |
| 192 |
| August 2009 |
| August 2009 (final data collection date for primary outcome measure) |
Inclusion Criteria:
- Back-related leg pain > 3 on 0 to 10 scale.
- Sub-acute or chronic back-related leg pain defined as current episode > 4 weeks duration.
- Back-related leg pain classified as 2, 3, 4, or 6 using the Quebec Task Force (QTF) Classification system. This includes radiating pain into the proximal or distal part of the lower extremity, with or without neurological signs, with possible compression of a nerve root.
- 21 years of age and older.
- Stable prescription medication plan (no changes in prescription medications that affect musculoskeletal pain in the previous month).
Exclusion Criteria:
- Ongoing treatment for leg or low back pain by other health care providers.
- Progressive neurological deficits or cauda equina syndrome.
- QTF classifications 5 (spinal fracture) and 11 (other diagnoses including visceral diseases, compression fractures, metastases). These are serious conditions not amenable to the conservative treatments proposed.
- QTF 7 (spinal stenosis syndrome characterized by pain and/or paresthesias in one or both legs aggravated by walking).
- Uncontrolled hypertension or metabolic disease.
- Blood clotting disorders.
- Severe osteoporosis.
- Inflammatory or destructive tissue changes of the spine.
- Patients with surgical lumbar spine fusion or patients with multiple incidents of lumbar surgery. This is a subgroup of low back pain patients which generally have a poorer prognosis.
- Pregnant or nursing women.
- Current or pending litigation. Patients seeking financial compensation tend to respond differently to treatment.
|
| Both |
| 21 Years and older |
| No |
|
|
| United States |
| |
| NCT00494065 |
| Gert Bronfort, DC, PhD, Northwestern Health Sciences University |
| R18HP07638, R18HP07638 |
| Northwestern Health Sciences University |
| Department of Health and Human Services |
| Principal Investigator: |
Gert Bronfort, DC, PhD |
Northwestern Health Sciences University |
|
|
| Northwestern Health Sciences University |
| March 2009 |